ENTITY
WuXi AppTec

WuXi AppTec (2359 HK)

523
Analysis
Health Care • China
WuXi AppTec Co., Ltd. manufactures medical products. The Company produces biological agents, antibodies, biological diagnostic reagents, and other products. WuXi AppTec also provides biological analysis, technical study, and other services.
more
bullish•Wuxi Biologics
•05 Nov 2023 08:25

ECM Weekly (5th Nov 2023)- Midea, WuxiXDC, Cello, Honasa, Qyuns, Ecopro, Lalatech, Mankind, TWE, VNT

Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.

Logo
536 Views
Share
bearish•WuXi AppTec
•02 Nov 2023 08:55

WuXi AppTec (2359.HK/603259.CH) 23Q3 - Will the TIDES Business Turn the Tide?

WuXi AppTec received Lilly's GLP-1 order, but it's too small to guarantee the reversal logic.23Q3 results sounded an alarm for investors.The savior...

Logo
639 Views
Share
bullish•WuXi AppTec
•01 Nov 2023 18:52•Broker

WuXi AppTec (603259 CH) – Peptide Business Becoming a New Growth Driver

WuXi AppTec reported 3Q23 revenue of RMB10,670mn, up 0.3% YoY, and attributable recurring net income of RMB2,948mn, up 23.8% YoY

Logo
287 Views
Share
bearish•WuXi XDC Cayman
•01 Nov 2023 18:21

WuXi XDC IPO: The Bear Case

The bear case rests on margins on a downward trend, large customer concentration, high related party transactions and volatile FCF generation.

Logo
612 Views
Share
bullish•WuXi XDC Cayman
•01 Nov 2023 08:55

Pre-IPO WuXi XDC (PHIP Updates) - Some Points Worth the Attention

WuXi XDC’s share price could perform well due to positive sentiments on ADC.But if the real market size of ADC is much smaller than PD...

Logo
540 Views
Share
x